Interim Report 1 January – 31 March 2023

Strong organic growth in both business areas

"Strong organic growth of 12 percent in the quarter reflects strong demand for our products and services. We are well-positioned for the recovery that is now taking place in health care and is expected to continue for a long time to come."
Fredrik Dalborg, CEO AddLife

AddLife´s interim report for Q1 2023 is now available online at the company website. The interim report can be downloaded in pdf version. Visit reports-en.add.life/interim-report-q1-2023

1 JANUARY – 31 MARCH 2023 (3 MONTHS)

• Net sales decreased by 5 percent to SEK 2,457m (2,579), partly driven by the fact that covid-19 related sales decreased to SEK 0m (510). Organic growth excluding covid-19 related turnover was 12 percent and acquired growth was 2 percent.
• EBITA amounted to SEK 366m (435), corresponding to an EBITA-margin of 14.9 percent (16.9). EBITA includes a reversed contingent consideration amounting to 83m, adjusted for this the EBITA-margin amounts to 11.5 percent.
• Profit after tax amounted to  SEK 174m (225).
• Earnings per share amounted to SEK 1.43 (1.85). Earnings per share for the last 12 months amounted to SEK 3.54 (5.91).
• Cash flow from operating activities amounted to SEK 105m (332).
• The equity ratio was 39 percent (38).
• Return on working capital (P/WC) amounted to 55 percent (61).

Stockholm, April 26, 2023
AddLife AB (publ)

For more information, contact;
Fredrik Dalborg, CEO [email protected], +46 70 516 09 01
Christina Rubenhag, CFO [email protected], +46 70 546 72 22
www.add.life

Video conference
Investors, analysts and the media are invited to a video conference at which Fredrik Dalborg, CEO and Christina Rubenhag, CFO will present the interim report. The presentation will be given in English and take about 20 minutes after which there will be an opportunity to ask questions. The meeting will be recorded and made available online.

The video conference will be at 10 a.m. CET on April 26, 2023
If you wish to participate via video conference, please follow this link>>

The presentation is also available on AddLife YouTube >>

AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has about 2,200 employees in some 85 operating subsidiaries. The Group currently has net sales of approximately SEK 9 billion. AddLife shares are listed on Nasdaq Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at April 26, 2023 at 07:45 a.m. CET.